A COMPARATIVE STUDY ON THE SAFETY RISKS AND FINANCIAL IMPACT OF TOPICAL STEROID MISUSE AMONG PATIENTS WHO SELF-MEDICATE VERSUS THOSE USING DOCTOR-PRESCRIBED TREATMENTS
Main Article Content
Keywords
Topical corticosteroids, misuse, dermatoses, self-medication
Abstract
Introduction Topical corticosteroids are presently the main medications used to address various dermatological conditions. However, they are often misapplied for a range of issues including acne, pigmentation, fungal infections, and itching, frequently being utilized as cosmetic products or skin creams for any form of rash. This research aims to evaluate the extent of adverse effects between groups of patients who have been prescribed these medications by practitioners and those who have self-prescribed. Furthermore, this study also examines the demographic and educational backgrounds of patients in whom topical steroids are most commonly misused.
Materials and Methods: This cross-sectional study was conducted in the GMC Ratlam. A total of 100 patients were enrolled after getting the informed consent for the study, and assessed based on their topical steroid misuse and their adverse effects. Results: The present study showed that steroid misuse was most common between 20 and 30 years of age group patients with low educational status. The most commonly applied steroid was clobetasol followed by mometasone and steroid abuse was more common in self-prescribed patients than physician-prescribed patients. The economic burden was more in the case of people using steroid cream because they have to be applied over a large body surface area. Incidence of adverse effects was observed more in self-prescribed patients and with low educational status.
Conclusion: This study highlights the fact that self-medication increases the incidence of adverse reactions and economic burden on the patients. Continuous education of patients and strict regulations regarding over-the-counter sales of steroids may help decrease the incidence of steroid misuse.
References
2. Kumar S, Goyal A, Gupta YK. Abuse of topical corticosteroids in India: Concerns and the way forward. J Pharmacol Pharmacother 2016; 7(1): 1–5. https://doi.org/10.4103/0976-500X.179364. 3. Rathod SS, Motghare VM, Deshmukh VS, et al. Prescribing practices of topical corticosteroids in the outpatient dermatology department of a rural tertiary care teaching hospital. Indian J Dermatol 2013; 58(5): 342–345. https://doi.org/10.4103/0019 5154.117293.
3. Nagesh TS, Akhilesh A. Topical steroid awareness and abuse: A prospective study among dermatology outpatients. Indian J Dermatol 2016; 61(6): 618–621. https://doi.org/10.4103/0019 5154.193666.
4. Rathi SK, D’Souza P. Rational and ethical use of topical cortico steroids based on safety and efficacy. Indian J Dermatol 2012; 57(4): 251–259. https://doi.org/10.4103/0019-5154.97655.
5. Meena S, Gupta LK, Khare AK, et al. Topical corticosteroids abuse: A clinical study of cutaneous adverse effects. Indian J Dermatol 2017; 62(6): 675. https://doi.org/10.4103/ijd. IJD_110_17
6. Inakanti Y, Thimmasarthi VN, Kumar S, et al. Topical corti costeroids: Abuse and Misuse. Our dermatology online. Nasza Dermatol Online 2015; 6(2): 130–134.
